Literature DB >> 25281718

Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.

David H Nguyen1, Haoxu Ouyang1, Jian-Hua Mao2, Lynn Hlatky3, Mary Helen Barcellos-Hoff4.   

Abstract

Age and physiologic status, such as menopause, are risk factors for breast cancer. Less clear is what factors influence the diversity of breast cancer. In this study, we investigated the effect of host age on the distribution of tumor subtypes in mouse mammary chimera consisting of wild-type hosts and Trp53 nullizygous epithelium, which undergoes a high rate of neoplastic transformation. Wild-type mammary glands cleared of endogenous epithelium at 3 weeks of age were subsequently transplanted during puberty (5 weeks) or at maturation (10 weeks) with syngeneic Trp53-null mammary tissue fragments and monitored for one year. Tumors arose sooner from adult hosts (AH) compared with juvenile hosts (JH). However, compared with AH tumors, JH tumors grew several times faster, were more perfused, exhibited a two-fold higher mitotic index, and were more highly positive for insulin-like growth factor receptor phosphorylation. Most tumors in each setting were estrogen receptor (ER)-positive (80% JH vs. 70% AH), but JH tumors were significantly more ER-immunoreactive (P = 0.0001) than AH tumors. A differential expression signature (JvA) of juvenile versus adult tumors revealed a luminal transcriptional program. Centroids of the human homologs of JvA genes showed that JH tumors were more like luminal A tumors and AH tumors were more like luminal B tumors. Hierarchical clustering with the JvA human ortholog gene list segregated luminal A and luminal B breast cancers across datasets. These data support the notion that age-associated host physiology greatly influences the intrinsic subtype of breast cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25281718      PMCID: PMC4252877          DOI: 10.1158/0008-5472.CAN-14-1440

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

Authors:  K B DEOME; L J FAULKIN; H A BERN; P B BLAIR
Journal:  Cancer Res       Date:  1959-06       Impact factor: 12.701

2.  Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

Authors:  W Ruan; D L Kleinberg
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

3.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.

Authors:  Sangjun Lee; Sheila Stewart; Iris Nagtegaal; Jingqin Luo; Yun Wu; Graham Colditz; Dan Medina; D Craig Allred
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

Review 5.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

6.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.

Authors:  T C Wang; R D Cardiff; L Zukerberg; E Lees; A Arnold; E V Schmidt
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

7.  Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

Authors:  B A Gusterson; R D Gelber; A Goldhirsch; K N Price; J Säve-Söderborgh; R Anbazhagan; J Styles; C M Rudenstam; R Golouh; R Reed
Journal:  J Clin Oncol       Date:  1992-07       Impact factor: 44.544

8.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

9.  Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

Authors:  Mei Zhang; Fariba Behbod; Rachel L Atkinson; Melissa D Landis; Frances Kittrell; David Edwards; Daniel Medina; Anna Tsimelzon; Susan Hilsenbeck; Jeffrey E Green; Aleksandra M Michalowska; Jeffrey M Rosen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

10.  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.

Authors:  Erick Román-Pérez; Patricia Casbas-Hernández; Jason R Pirone; Jessica Rein; Lisa A Carey; Ronald A Lubet; Sendurai A Mani; Keith D Amos; Melissa A Troester
Journal:  Breast Cancer Res       Date:  2012-03-19       Impact factor: 6.466

View more
  2 in total

1.  Mammary Tumor-Derived Transplants as Breast Cancer Models to Evaluate Tumor-Immune Interactions and Therapeutic Responses.

Authors:  Jade Moore; Lin Ma; Ann A Lazar; Mary Helen Barcellos-Hoff
Journal:  Cancer Res       Date:  2021-12-13       Impact factor: 13.312

2.  From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer.

Authors:  Hang Chang; Xu Yang; Jade Moore; Xiao-Ping Liu; Kuang-Yu Jen; Antoine M Snijders; Lin Ma; William Chou; Roberto Corchado-Cobos; Natalia García-Sancha; Marina Mendiburu-Eliçabe; Jesus Pérez-Losada; Mary Helen Barcellos-Hoff; Jian-Hua Mao
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.